Article Sidebar
Views pdf: 118
GLYCEMIC CONTROL IN PATIENT WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
Main Article Content
Abstract
Introduction: Type 2 diabetes is a common cardiovascular risk factor in Vietnam. Newly diagnosed diabetic patients need to aggressively manage blood glucose to minimize the development of cardio-renal complications. Objective: This study was conducted to determine the rate of blood glucose control in newly diagnosed type 2 diabetic patients. Methods: A descriptive cross-sectional study was conducted on type 2 diabetic patients diagnosed within the last 6 months at the Endocrinology clinic and Family Medicine clinic, Ho Chi Minh City University Medical Center. Results: 275 newly diagnosed type 2 diabetic patients participated in the study. The rate of blood glucose control (HbA1C < 7%) was 44.7%. Factors associated with the risk of poor blood glucose control included: overweight/obesity (OR 0.4, 95% CI 0.2-0.7), smoking (OR 3.0, 95% CI 1.3-6.6), comorbidities (OR 17.7, 95% CI 1.3-85.2), sulfonylurea use (OR 2.2, 95% CI 1.1-4.7) and hypoglycemic combination therapy (OR 3.0, 95% CI 1.4-6.6). Conclusion: Newly diagnosed type 2 diabetic patients have a suboptimal rate of blood glucose control. Those who smoke or have comorbidities require special attention to achieve target blood glucose levels.
Article Details
Keywords
Newly diagnosed type 2 diabetes, blood glucose control
References
2. Biswas T, Tran N, Thi My Hanh H, et al. Type 2 diabetes and hypertension in Vietnam: a systematic review and meta-analysis of studies between 2000 and 2020. BMJ Open. 2022 Aug 8;12(8):e052725.
3. Adler AI, Coleman RL, Leal J, et al. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91). Lancet. 2024 May 17:S0140-6736(24)00537-3. doi: 10.1016/S0140-6736(24)00537-3.
4. Cai X, Hu D, Pan C, et al. Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort study. J Diabetes Investig. 2020 Jan;11(1):151-161. doi: 10.1111/ jdi.13092.
5. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị đái tháo đường típ 2 (Ban hành kèm theo Quyết định số 5481/QĐ-BYT ngày 30 tháng 12 năm 2020). https://daithaoduong.kcb.vn/huong-dan-chan-doan-va-dieu-tri-dai-thao-duong-tip-2
6. ElSayed NA, Aleppo G, Aroda VR, et al, on behalf of the American Diabetes Association. 6. Glycemic Targets: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
7. Lachin JM, Nathan DM; DCCT/EDIC Research Group. Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care. 2021 Sep 21;44(10):2216–24. doi: 10.2337/dc20-3097.
8. Wang J, Yan R, Wen J, et al. Association of lower body mass index with increased glycemic variability in patients with newly diagnosed type 2 diabetes: a cross-sectional study in China. Oncotarget. 2017 Apr 14;8(42):73133-73143. doi: 10.18632/oncotarget.17111.
9. Hussain S, Chowdhury TA. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus. Drugs. 2019 Feb;79(3):231-242. doi: 10.1007/s40265-019-1061-4.
10. Chen Z, Liu XA, Kenny PJ. Central and peripheral actions of nicotine that influence blood glucose homeostasis and the development of diabetes. Pharmacol Res. 2023 Aug;194:106860. doi: 10.1016/j.phrs.2023.106860.